Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (8706)	7/12/2000 10:03:03 AM
From: scaram(o)uche	Read Replies (3) \| Respond to of 9262

Ray.... please continue to watch NBSC. Illiquid as heck, and tons waiting to recoup from the March highs, but.... just fundamentally cheap, cheap, cheap and facing trickle down from genomics. DGI, their 80%-owned biotech, has very nice wording in an issued patent claim, wording that has been noticed by Novo Nordisk. When and if it goes, it could be a super sto. Volume is too low for anyone to make a call? VPHM tucked above 25 for 220K shares in first 30 minutes this morning. Now that's a nice sto. BTRN too..... should, IMO, encounter nicer levels if MEDI transitions to subcutaneous 507 for psoriasis. Carson Group affiliate has apparently (Yahoo thread, I disclaim any direct knowledge) said that such transition is scheduled for this month. :-) Where's Carol??